Sort
10,829 grants matching “car t”
Characterizing and Targeting the Novel IL-15- AKT-XBP1s Pathway in NK Cells
$445,687Jianhua Yu · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA
Characterizing and Targeting the Novel IL-15- AKT-XBP1s Pathway in NK Cells
$445,687Jianhua Yu · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
Phenotypic variability within isogenic population of lymphocytes
$445,550Gregoire Altan-Bonnet · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Brief Child Safety Interventions in Emergency Department
$445,515Johns Hopkins University · R01 · FY2002 · HD
CAREER: Cyber-enabled Multiscale Methodology for Hybrid Soft Materials-based Nanoparticle Design
$445,401Meenakshi Dutt · Rutgers University New Brunswick · · FY2017 · MPS
Intensive Daily Measurement of Simultaneous Alcohol and Marijuana Use in a High-Risk Community Sample of Young Adults: Impacts on Acute and Longer-term Use and Consequences
$445,026Christine M Lee · University Of Washington · R01 · FY2017 · AA
TARGETING ROR1 WITH CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
$444,969Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
Improving genetically engineered T cells for medulloblastomas
$444,775Giedre Krenciute · St. Jude Children'S Research Hospital · R01 · FY2021 · NS
Improving genetically engineered T cells for medulloblastomas
$444,775Giedre Krenciute · St. Jude Children'S Research Hospital · R01 · FY2025 · NS
Improving genetically engineered T cells for medulloblastomas
$444,775Giedre Krenciute · St. Jude Children'S Research Hospital · R01 · FY2022 · NS
Improving genetically engineered T cells for medulloblastomas
$444,775Giedre Krenciute · St. Jude Children'S Research Hospital · R01 · FY2023 · NS
The Impact of Telelactation Services on Breastfeeding Outcomes among Minority Mothers: Siteless Tele-MILC Trial
$444,671Lori Uscher-Pines · Rand Corporation · R01 · FY2021 · NR
Molecular modeling of G protein-coupled receptors
$444,483Stefano Costanzi · Diabetes, Digestive, Kidney Diseases · Z01 · FY2007 · DK
Exploiting the immunomodulatory effects of sulindac and novel non-COX inhibitory derivatives for cancer treatment
$444,328Gang Zhou · Augusta University · R01 · FY2020 · CA
Scalable Approach to Optimal Control Design for Large-dimensional Systems Using Operator Theoretic Methods
$444,199Umesh Vaidya · Clemson University · · FY2025 · ENG
American Indian mHealth Smoking Dependence study (PQ4)
$444,040Daniel G Petereit · Rapid City Regional Hospital · R01 · FY2012 · CA
Isoform-specific Regulation of the Coxsackie and Adenovirus Receptor in Polarized Epithelia
$444,000Katherine Julie Excoffon · Wright State University · R15 · FY2015 · AI
Enhanced imaging and treatment of aggressive subtypes of prostate cancer
$443,607Martin G Pomper · Johns Hopkins University · R01 · FY2022 · CA
DESIGN AND TESTING OF DUAL-TARGETED FINE-TUNED IMMUNE-RESTORING (DFIR) CAR T-CELL THERAPY TO ACHIEVE CURES OF HIGH-GRADE SEROUS OVARIAN CANCER.
$443,178Dana-Farber Cancer Institute, Inc. · · FY2022 · Defense Health Agency
(PQ6)Nuclear receptor mechanisms in circadian disruption induced hepatocarcinogenesis
$443,175Loning None Fu · Baylor College Of Medicine · R01 · FY2019 · CA
Ameliorating off-target toxicities of CAR T cells by engineering NOT gates
$442,900Wendell A Lim · University Of California, San Francisco · R01 · FY2023 · CA
African Rigorous Innovative Stroke Epidemiological Surveillance (ARISES)
$442,804Mayowa Ojo Owolabi · College Of Medicine, University Of Ibadan · R01 · FY2020 · NS
(PQ6)Nuclear receptor mechanisms in circadian disruption induced hepatocarcinogenesis
$442,560Loning None Fu · Baylor College Of Medicine · R01 · FY2018 · CA
Conditional control of universal antigen receptor signaling
$442,414Jason Jakob Lohmueller · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · GM
Conditional control of universal antigen receptor signaling
$442,414Jason Jakob Lohmueller · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · GM